Makers Laboratories Rights Issue 2022 Date, Price, Form, Allotment & Ratio

IPO Initial Public Offerings
Makers Laboratories rights issue date is fixed, The right issue is to start on 18 April 2022 and will close on 27 April 2022. The Makers Laboratories rights issue record date is 01 April 2022. The entitlement ratio is 1:5, 1 right share for every 5 fully-paid equity shares held on the record date. Check out Makers Laboratories’s rights issue details.
Makers Laboratories

    Makers Laboratories Rights Issue 2022 Dates

     Rights Issue Open: 18 April 2022
     Rights Issue Close: 27 April 2022
     Rights Record Date: 01 April 2022
     Deemed Date of Allotment 06 May 2022
     Renunciation of Rights Entitlements 22 April 2022

    Makers Laboratories Rights Issue 2022 Offer Details

     Rights Issue Size: Approx ₹14.75 Crores 
     Price Band: ₹150 Per Equity Share
     Face Value: ₹10 Per Equity Share
     Listing on: BSE
     Entitlement Ratio:  1:5 (1 rights share for every 5 shares)
     Equity: 10,00,000 Equity Share
     Live Share Price: Click Here

    About Company – Makers Laboratories

    Makers Laboratories Limited is a rapidly growing Indian Pharmaceutical company with a strong thrust on Branded Generics. We make life easier by offering high-quality products at affordable prices. Our product portfolio covers a wide range of General Health Therapeutic segments. The Branded Generic Pharmaceutical Formulations such as Duramol (Paracetamol), Artemak-AB (α-β Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffin (Anti cough Range), and Exylin (Amoxycillin range). They have a strong distribution network of 20 Consignment Agents and 15 Super Stockiest, catering to more than 1500 Stockiest, 1,00,000 Doctors, and 2,00,000 Retailers.

    Makers Laboratories Rights Issue 2022 Form & How to Apply

    How to apply the Makers Laboratories rights issue? You can check Makers Laboratories rights issue details on click here. You can apply the Makers Laboratories rights issue via form download on NSE & BSE website where you can download blank forms & submit them to your bank or broker. You can apply online via ASBA or UPI via your Demat account details.

    Makers Laboratories Financial Report

      ₹ in Crores
    YearRevenueExpensePAT
    2019₹49₹452.45
    2020₹52₹49-₹0.12
    2021₹45₹43-₹1.62

    Quick Links

    Makers Laboratories Rights Issue 2022 Allotment Status

    Link Intime India Private Limited
    C-101, 247 Park, L.B.S. Marg, Vikhroli (West),
    Mumbai 400 083 Telephone: +91 (22) 4918 6200
    Website: www.linkintime.co.in  
    Investor grievance e-mail: [email protected]
    Check Makers Laboratories issue on Linkintime website allotment URL. Click Here

    Makers Laboratories Rights Issue 2022 Lead Managers

    • Arihant Capital Markets Ltd

      Company Address:

      Makers Laboratories Limited
      54-D, Kandivli Industrial Estate,
      Kandivli (W), Mumbai, 400067
      Phone: 022-28688544
      Website: https://www.makerslabs.com/

      Makers Laboratories Rights Issue 2022 FAQs:

      When is Makers Laboratories Rights Issue 2022 Open Date?

      Makers Laboratories Rights Issue 2022 open date is 18 April 2022.

      When is Makers Laboratories Rights Issue 2022 Record Date?

      Makers Laboratories Rights Issue 2022 record date is 01 April 2022.

      What is Makers Laboratories Rights Issue 2022 Price?

      The company has fixed the price at ₹150 per equity share.

      What is the Makers Laboratories Rights Issue 2022 Ratio?

      The company has fixed the ratio 1:5, 1 Rights Equity Share for every 5 Equity Shares as on record date.

      How to apply for Makers Laboratories Rights Issue 2022?

      As per the record date you need to have Makers Laboratories shares in your Demat account. You can participate in Rights Issue via offline form download or you can apply online via ASBA or UPI options.

      Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

        Share the Post:
        Facebook
        Twitter
        LinkedIn